A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals

Clinical trial NCT05472038 · COMPLETED

Trial details

NCT number: NCT05472038
Sponsor: BioNTech SE
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection COVID-19

Start date: 2022-07-26
Primary completion: 2024-03-26
Enrollment: 1453

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.